Ledger.Open graph →
SEC Form D · filed January 6, 2017

AILERON THERAPEUTICS INC

Offering
$40.0M
Sold
$30.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Greg Buchholz · Chicago, ILDirectorFox Point Performance LP · New York, NYDirectorArmen H. Shanafelt · Cambridge, MADirectorJohn H. Mcarthur · Cambridge, MADirectorBrian M. Gallagher, Jr · Cambridge, MADirectorFox Point Capital Management LLC · New York, NYDirectorReinhard J. Ambros · Cambridge, MADirectorChristina Yeung · San Francisco, CADirectorManuel H. Aivado · Cambridge, MAExecSeth L. Harrison · Cambridge, MADirectorJoshua Weissburg · San Francisco, CAExec · DirectorChuck Teubner · Chicago, ILDirectorJoseph A. Yanchik Iii · Cambridge, MAExec · DirectorCaleb H. Winder · Cambridge, MADirectorShober Holdings LLC · New York, NYDirectorCaleb H. Winder · Cambridge, MADirectorManuel H. Aivado · Cambridge, MAExecDhruvkaran Mehta · San Francisco, CAExec · DirectorBill Burgess · Chicago, ILDirectorScott L. Kapnick · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗